Further clinical data on the more rapid achievement of remission without the use of steroids with tocilizumab compared to methotrexate in giant-cell arteritis

Intern Emerg Med. 2024 Nov 4. doi: 10.1007/s11739-024-03769-3. Online ahead of print.

Lukasz Szarpak^{1

2}, Basar Cander³, Michal Pruc^{4

5}

¹ Henry JN Taub Department of Emergency Medicine, Baylor College of Medicine, One Baylor Plaza, BCM285, Houston, TX, 77030, USA. Lukasz.szarpak@gmail.com.
² Department of Clinical Research and Development, LUXMED Group, Warsaw, Poland. Lukasz.szarpak@gmail.com.
³ Department of Emergency Medicine, Bezmialem Vakif University, Fatih, Istanbul, Turkey.
⁴ Department of Clinical Research and Development, LUXMED Group, Warsaw, Poland.
⁵ Department of Public Health, International European University, Kiev, Ukraine.

No abstract available

Keywords: Giant cell arteritis; Methotrexate; Steroid-free remission; Tocilizumab.